Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
基本信息
- 批准号:7437569
- 负责人:
- 金额:$ 23.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferApoptosisAttenuatedAutoimmune DiseasesAutoimmunityBiochemicalCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellsCessation of lifeColitisComplexDevelopmentEffector CellExcisionFailureGene ExpressionGenerationsGeneric DrugsGenesIL2 geneImmune responseImmune systemIn VitroInterleukin-2Leucocytic infiltrateMature T-LymphocyteMediatingMolecularMusNumbersOrganPeptide/MHC ComplexPeripheralPhenotypePhosphorylationPlayProcessProtein OverexpressionPublic HealthRegulationRoleSignal TransductionSpecificitySpleenStagingSystemT-Cell DevelopmentT-LymphocyteThymic epithelial cellThymus GlandTranscriptional RegulationWasting Syndromeattenuationgene repressionimmune functionleukemogenesislymph nodesmouse modelneglectnovelprogramsresearch studythymocytetranscription factor
项目摘要
DESCRIPTION (provided by applicant): The fate of double positive thymocytes is dictated by the strength and duration of the interaction between TCR and self peptide-MHC complex presented on the cortical thymic epithelial cells. A weak interaction results in positive selection and survival signals which rescue DP thymocytes from death by neglect. Positive selection is critical for immune function, as this is the process by which a repertoire of T cells bearing useful TCR specificities is produce. However little is known about the transcriptional control of positive selection. We found that the transcription factor BCL11B controls early steps of positive selection, as removal results in attenuated TCR signaling and failure of positive selection. In addition, in the absence of BCL11B DP thymocytes have reduced survival even in the absence of TCR signaling, demonstrating that BCL11B is a major player in the control of survival of DP thymocytes. Supporting our hypothesis that BCL11B is critical for positive selection and survival of DP thymocytes we have evidence that BCL11B controls expression of genes associated with positive selection and survival of DP thymocytes. In addition, in the absence of BCL11B starting with DP stage of T cell development the reduced number of peripheral BCL11B-deficient T lymphocytes present an activated phenotype and mice develop wasting disease and colitis. Conditional removal of BCL11B in mature T cells also results in increased number of activated CD4+ T cells. These results support the hypothesis that BCL11B regulates mature CD4+ T lymphocytes. Using conditional and inducible mouse system and biochemical studies we propose to investigate the mechanisms by which BCL11B controls positive selection and survival of DP thymocytes through transcriptional control of gene expression. In addition we propose to determine the role of BCL11B in conventional and T regulatory CD4+ T cells. Public Health Relevance Statement: The results of these studies will contribute significantly to a molecular understanding of positive selection and survival of DP thymocytes, which both play a crucial role in generation of the appropriate T cells for an adequate immune response. In addition, these studies will contribute to understanding transcriptional program of effector CD4+ T and CD4+ T regulatory cells, and have important implications for autoimmune diseases.
描述(申请人提供):双阳性胸腺细胞的命运由胸腺皮质上皮细胞上的TCR和自体多肽-MHC复合体相互作用的强度和持续时间决定。弱的相互作用导致积极的选择和生存信号,通过忽视将DP胸腺细胞从死亡中拯救出来。阳性选择对免疫功能至关重要,因为这是产生具有有用的TCR特异性的T细胞的过程。然而,人们对正选择的转录调控知之甚少。我们发现转录因子BCL11B控制着正选择的早期步骤,因为去除BCL11B会导致TCR信号减弱和正选择失败。此外,在缺乏BCL11B的情况下,即使在没有TCR信号的情况下,DP胸腺细胞的存活率也会降低,这表明BCL11B是控制DP胸腺细胞存活的主要因素。支持我们的假设,即BCL11B对阳性选择和DP胸腺细胞的存活至关重要,我们有证据表明BCL11B控制着与阳性选择和DP胸腺细胞存活相关的基因的表达。此外,在缺乏BCL11B的情况下,从T细胞发育的DP阶段开始,外周血中缺乏BCL11B的T淋巴细胞数量减少,呈现激活的表型,小鼠出现衰减性疾病和结肠炎。有条件地去除成熟T细胞中的BCL11B也会导致激活的CD4+T细胞数量增加。这些结果支持BCL11B调节成熟的CD4+T淋巴细胞的假设。利用条件性和可诱导性小鼠系统和生化研究,我们建议研究BCL11B通过转录控制基因表达来控制阳性选择和DP胸腺细胞存活的机制。此外,我们建议确定BCL11B在常规和T调节的CD4+T细胞中的作用。公共卫生相关声明:这些研究的结果将大大有助于从分子上理解阳性选择和DP胸腺细胞的存活,这两者在产生适当的T细胞以进行充分的免疫反应方面都起着至关重要的作用。此外,这些研究将有助于了解效应器CD4+T和CD4+T调节细胞的转录程序,并对自身免疫性疾病具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dorina Avram其他文献
Dorina Avram的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dorina Avram', 18)}}的其他基金
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
- 批准号:
10667165 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
高通量筛选分析,鉴定针对 Hectd3 的化学探针,Hectd3 是一种与多发性硬化症有关的 E3 泛素连接酶
- 批准号:
10391539 - 财政年份:2021
- 资助金额:
$ 23.55万 - 项目类别:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
高通量筛选分析,鉴定针对 Hectd3 的化学探针,Hectd3 是一种与多发性硬化症有关的 E3 泛素连接酶
- 批准号:
10597043 - 财政年份:2021
- 资助金额:
$ 23.55万 - 项目类别:
Tolerogenic dual microparticle system for treatment of multiple sclerosis
用于治疗多发性硬化症的致耐受性双微粒系统
- 批准号:
9918870 - 财政年份:2017
- 资助金额:
$ 23.55万 - 项目类别:
Transcriptional control in innate lymphoid type II cells
先天淋巴细胞 II 型细胞的转录控制
- 批准号:
8732115 - 财政年份:2014
- 资助金额:
$ 23.55万 - 项目类别:
Transcriptional control in innate lymphoid type II cells
先天淋巴细胞 II 型细胞的转录控制
- 批准号:
8853814 - 财政年份:2014
- 资助金额:
$ 23.55万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
8021853 - 财政年份:2008
- 资助金额:
$ 23.55万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
7760538 - 财政年份:2008
- 资助金额:
$ 23.55万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
8213720 - 财政年份:2008
- 资助金额:
$ 23.55万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 23.55万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 23.55万 - 项目类别:
Discovery Grants Program - Individual